Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical Inc (NQ: SWAV )

330.05 -0.14 (-0.04%)
Streaming Delayed Price Updated: 10:47 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
ShockWave Medical Inc (SWAV) Q3 2021 Earnings Call Transcript
SWAV earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
ShockWave Medical: Q3 Earnings Insights
ShockWave Medical (NASDAQ:SWAV) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
What 9 Analyst Ratings Have To Say About ShockWave Medical
ShockWave Medical (NASDAQ:SWAV) has observed the followin... 
Via Benzinga
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
Earnings Outlook For ShockWave Medical
ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Shockwave IVL Shows Consistent Treatment Of Calcium In Real-World Study
Shockwave Medical Inc (NASDAQ: SWAV) has announced interim analysis from the Disrupt PAD III Observational Study evaluating the Intravascular Lithotripsy (IVL)... 
Via Benzinga
Shockwave Medical Insider Trades $877 Thousand In Company Stock
Frank T Watkins, Director at Shockwave Medical (NASDAQ:SWAV), made a large insider sell on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Did Shockwave Medical Stock Gain 18% in August?
The medical device stock is growing even quicker than investors anticipated. 
Via The Motley Fool
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
This Healthcare Stock Grew Revenue by More Than 400% in the Second Quarter
Here's one innovative company you might want to put on your radar. 
Via The Motley Fool
ShockWave Medical Inc (SWAV) Q2 2021 Earnings Call Transcript
SWAV earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Shockwave Medical Surged as High as 10% Today
Top- and bottom-line beats plus raised guidance made for a very healthy stock on Monday. 
Via The Motley Fool
Shockwave Medical Reports Narrower Than Expected Q2 Loss; Guides Above Consensus
Shockwave Medical Inc's (NASDAQ: SWAV) second-quarter FY21 sales were up 4-fold to $55.9 million beating the Wall Street consensus of $45.17 million. The... 
Via Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs. Facts of Interest: The largest company by market cap to set a new 52-week high was Alphabet (... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 30.38% to $2.36 during Monday's pre-market session. The company's market cap stands at $61.9 million. The... 
Via Benzinga
ShockWave Medical: Q2 Earnings Insights
Shares of ShockWave Medical (NASDAQ:SWAV) moved higher by 0.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 98.... 
Via Benzinga
3 Ridiculously Overpriced Stocks That Could Crash in a Market Correction
Now may be the time to sell these stocks before their bubbles pop. 
Via The Motley Fool
SVB Leerink Believes ShockWave Is Well-Positioned In Calcified Cardiovascular Market
SVB Leerink has initiated the coverage of ShockWave Medical Inc (NASDAQ: SWAV) with an Outperform rating and a $208 price target, implying an upside of... 
Via Benzinga
ShockWave Medical Insights: Return On Capital Employed
During Q1, ShockWave Medical's (NASDAQ:SWAV) reported sales totaled $31.90 million. Despite a 10.22% in earnings, the company posted a loss of $17.49 million. In Q4, ShockWave... 
Via Benzinga
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2021
Upgrades According to Macquarie, the prior rating for 2U Inc (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was... 
Via Benzinga
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.